X4 Pharmaceuticals (XFOR) Short-term Investments (2017 - 2019)

X4 Pharmaceuticals' Short-term Investments history runs 3 years deep, the most recent figure standing at $3.2 million for Q2 2019.

• Quarterly Short-term Investments rose 6101.96% year-over-year to $3.2 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $3.2 million (up 6101.96% YoY) and the FY2018 annual result came in at $101000.0, changed N/A from the prior year.
• Short-term Investments was $3.2 million for Q2 2019 at X4 Pharmaceuticals, up from $101000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $8.4 million in Q2 2017 and bottomed at $51000.0 in Q1 2018.
• A 3-year average of $2.3 million and a median of $848000.0 in 2017 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2018 — Short-term Investments plunged 99.39% — and 2019, when it soared 6101.96%.
• X4 Pharmaceuticals' Short-term Investments stood at $5.1 million in 2017, then slumped by 98.03% to $101000.0 in 2018, then soared by 3031.68% to $3.2 million in 2019.
• Business Quant data shows XFOR's Short-term Investments at $3.2 million in Q2 2019, $101000.0 in Q4 2018, and $51000.0 in Q3 2018.